WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Breast Cancer Endpoints - Master Primary v3, Tumor assessment provides_evidence_for Disease recurrence, Adjuvant setting endpoints has_component Disease free survival (DFS), Date of recurrence has_component Tumor assessment, Concepts (e.g. CRF:pCR:Surgical margins are denoted by solid round-edged rectangle, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_tumor_information Tumor information, Pathologic complete response (pCR) is_assessed_with Surgical Intervention, Curative intent has_option Neoadjuvant setting endpoints, Therapeutic Efficacy Point has Observation or Assessment, Disease free survival (DFS) has_pertinent_information No disease present, Date of progression has_component Tumor assessment, Disease free survival (DFS) ends_concurrent_with Date of recurrence, Therapeutic Efficacy Point has Therapeutic/Surgical intervention, Progression free survival (PFS) ends_concurrent_with Death of any cause, Disease free survival (DFS) starts_concurrent_with Date of Randomization, Cancer stage has_component M, Hormone receptor status has_component PR status, Neoadjuvant setting endpoints has_component Overall Survival (OS), Curative intent has_option Adjuvant setting endpoints, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_medical_history_information Demographics/Medical history, Cancer stage has_component T